borderline significantp = 0.06
Stage IV disease demonstrated a borderline significant association with worse disease-free survival, with a HR of 2.81 (95% CI 0.96–8.27, p = 0.06) compared to stages I-III.
Stage IV disease demonstrated a borderline significant association with worse disease-free survival, with a HR of 2.81 (95% CI 0.96–8.27, p = 0.06) compared to stages I-III.
Smoking history showed a trend toward increased recurrence risk with a HR of 1.61 (95% CI 0.85–3.04, p = 0.14), though this did not reach statistical significance.